BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32895194)

  • 1. [Integrin α5 silencing inhibits proliferation, invasion and metastasis of human liver cancer Bel-7404 cells
    Guo Y; Xu G; Shan M; Yang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):893-898. PubMed ID: 32895194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
    Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
    Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
    Fan QC; Tian H; Wang Y; Liu XB
    Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial-Mesenchymal Transition.
    Deng Y; Wan Q; Yan W
    Cancer Manag Res; 2019; 11():9609-9620. PubMed ID: 32009816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITGA5 Promotes Tumor Progression through the Activation of the FAK/AKT Signaling Pathway in Human Gastric Cancer.
    Wang JF; Chen YY; Zhang SW; Zhao K; Qiu Y; Wang Y; Wang JC; Yu Z; Li BP; Wang Z; Chen JQ
    Oxid Med Cell Longev; 2022; 2022():8611306. PubMed ID: 36193075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
    Pantano F; Croset M; Driouch K; Bednarz-Knoll N; Iuliani M; Ribelli G; Bonnelye E; Wikman H; Geraci S; Bonin F; Simonetti S; Vincenzi B; Hong SS; Sousa S; Pantel K; Tonini G; Santini D; Clézardin P
    Oncogene; 2021 Feb; 40(7):1284-1299. PubMed ID: 33420367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ITGA5 down-regulation on the migration capacity of human dental pulp stem cells.
    Xu S; Cui L; Ma D; Sun W; Wu B
    Int J Clin Exp Pathol; 2015; 8(11):14425-32. PubMed ID: 26823759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
    Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
    Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Rab11 gene expression on the invasion and migration of cervical cancer cell line SiHa in hypoxia].
    Xu H; Yuan Y; Ji JY; Jiang Q; Niu LJ; Liu NL; Zhang LZ; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):928-933. PubMed ID: 28057129
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
    Yan T; Ye XX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MiR-204 inhibits invasion and metastasis of breast cancer cells by targeted regulation of HNRNPA2B1].
    Zhang L; Bai J; Hu Y; Zhou D; Zheng Q; Yin C; Mu Q; Li H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):869-875. PubMed ID: 32895200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of integrin-α5 in the proliferation and odontogenic differentiation of human dental pulp stem cells.
    Cui L; Xu S; Ma D; Gao J; Liu Y; Yue J; Wu B
    J Endod; 2014 Feb; 40(2):235-40. PubMed ID: 24461410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integrin α5 promotes the proliferation, invasion and adhesion of gastric cancer by regulating the FAK/Src/Rac1 signaling pathway].
    Yao HB; Shao QS; Shao YF; Hu JF
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2692-2697. PubMed ID: 34510875
    [No Abstract]   [Full Text] [Related]  

  • 17. O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer.
    Yu M; Chu S; Fei B; Fang X; Liu Z
    Exp Cell Res; 2019 Sep; 382(2):111464. PubMed ID: 31202709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional elucidation and methylation-mediated downregulation of ITGA5 gene in breast cancer cell line MDA-MB-468.
    Fang Z; Yao W; Xiong Y; Zhang J; Liu L; Li J; Zhang C; Wan J
    J Cell Biochem; 2010 Aug; 110(5):1130-41. PubMed ID: 20564209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
    Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
    Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
    J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.